Age-related macular degeneration (AMD) is the most common cause of blindness in the elderly population worldwide and is\ndefined as a chronic, progressive disorder characterized by changes occurring within themacula reflective of the ageing process. At\npresent, the prevalence of AMD is currently rising and is estimated to increase by a third by 2020. Although our understanding of\nthe several components underpinning the pathogenesis of this condition has increased significantly, the treatment options for this\ncondition remain substantially limited. In this review, we outline the existing arsenal of therapies available for AMD and discuss\nthe additional role of further novel therapies currently under investigation for this debilitating disease.
Loading....